PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 34 filers reported holding PSYCHEMEDICS CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $572,597 | -12.9% | 144,231 | 0.0% | 0.04% | -7.3% |
| Q2 2023 | $657,693 | -13.1% | 144,231 | 0.0% | 0.04% | -25.5% |
| Q1 2023 | $757,213 | +7.1% | 144,231 | 0.0% | 0.06% | +3.8% |
| Q4 2022 | $707,000 | -24.0% | 144,231 | 0.0% | 0.05% | -32.1% |
| Q3 2022 | $930,000 | -2.3% | 144,231 | 0.0% | 0.08% | +18.2% |
| Q2 2022 | $952,000 | -4.4% | 144,231 | 0.0% | 0.07% | +3.1% |
| Q1 2022 | $996,000 | -1.6% | 144,231 | 0.0% | 0.06% | +3.2% |
| Q4 2021 | $1,012,000 | -16.4% | 144,231 | 0.0% | 0.06% | -8.8% |
| Q3 2021 | $1,211,000 | +20.6% | 144,231 | 0.0% | 0.07% | +21.4% |
| Q2 2021 | $1,004,000 | +12.2% | 144,231 | 0.0% | 0.06% | 0.0% |
| Q1 2021 | $895,000 | +123.8% | 144,231 | +83.7% | 0.06% | +80.6% |
| Q4 2020 | $400,000 | -43.3% | 78,495 | -8.2% | 0.03% | -20.5% |
| Q3 2020 | $705,000 | +61.7% | 85,495 | +8.9% | 0.04% | -17.0% |
| Q2 2020 | $436,000 | -8.2% | 78,495 | 0.0% | 0.05% | -24.2% |
| Q1 2020 | $475,000 | -33.8% | 78,495 | 0.0% | 0.06% | -10.1% |
| Q4 2019 | $718,000 | +0.4% | 78,495 | 0.0% | 0.07% | -13.8% |
| Q3 2019 | $715,000 | -9.7% | 78,495 | 0.0% | 0.08% | 0.0% |
| Q2 2019 | $792,000 | -28.1% | 78,495 | 0.0% | 0.08% | -38.0% |
| Q1 2019 | $1,101,000 | -21.1% | 78,495 | -10.7% | 0.13% | -29.1% |
| Q4 2018 | $1,395,000 | -14.8% | 87,917 | +1.0% | 0.18% | +2.2% |
| Q3 2018 | $1,637,000 | +8.4% | 87,017 | +10.9% | 0.18% | +0.6% |
| Q2 2018 | $1,510,000 | -10.0% | 78,495 | 0.0% | 0.18% | -11.5% |
| Q1 2018 | $1,677,000 | +3.9% | 78,495 | 0.0% | 0.20% | +12.4% |
| Q4 2017 | $1,614,000 | +11.5% | 78,495 | 0.0% | 0.18% | -2.7% |
| Q3 2017 | $1,447,000 | -26.1% | 78,495 | 0.0% | 0.18% | -28.8% |
| Q2 2017 | $1,958,000 | +24.4% | 78,495 | 0.0% | 0.26% | +19.0% |
| Q1 2017 | $1,574,000 | -18.7% | 78,495 | 0.0% | 0.22% | -21.7% |
| Q4 2016 | $1,937,000 | +24.5% | 78,495 | 0.0% | 0.28% | +3.8% |
| Q3 2016 | $1,556,000 | +44.2% | 78,495 | 0.0% | 0.27% | +24.3% |
| Q2 2016 | $1,079,000 | 0.0% | 78,495 | 0.0% | 0.21% | +3.4% |
| Q1 2016 | $1,079,000 | +35.6% | 78,495 | 0.0% | 0.21% | +38.0% |
| Q4 2015 | $796,000 | +0.9% | 78,495 | 0.0% | 0.15% | -8.5% |
| Q3 2015 | $789,000 | -32.2% | 78,495 | 0.0% | 0.16% | -25.5% |
| Q2 2015 | $1,164,000 | -10.6% | 78,495 | 0.0% | 0.22% | -16.7% |
| Q1 2015 | $1,302,000 | +9.5% | 78,495 | 0.0% | 0.26% | +7.3% |
| Q4 2014 | $1,189,000 | +7.0% | 78,495 | 0.0% | 0.25% | -3.5% |
| Q3 2014 | $1,111,000 | 0.0% | 78,495 | 0.0% | 0.26% | -4.5% |
| Q2 2014 | $1,111,000 | -17.4% | 78,495 | 0.0% | 0.27% | -18.6% |
| Q1 2014 | $1,345,000 | +16.7% | 78,495 | 0.0% | 0.33% | +20.1% |
| Q4 2013 | $1,153,000 | +10.9% | 78,495 | 0.0% | 0.27% | -1.1% |
| Q3 2013 | $1,040,000 | +23.4% | 78,495 | 0.0% | 0.28% | +15.0% |
| Q2 2013 | $843,000 | – | 78,495 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 40,001 | $276,000 | 0.13% |
| SANTA MONICA PARTNERS LP | 20,000 | $138,000 | 0.10% |
| Invenomic Capital Management LP | 135,631 | $769,000 | 0.08% |
| Cannell Capital | 78,306 | $540,000 | 0.08% |
| RBF Capital, LLC | 144,231 | $996,000 | 0.06% |
| CRAWFORD INVESTMENT COUNSEL INC | 266,502 | $1,839,000 | 0.04% |
| Ancora Advisors LLC | 80,728 | $557,000 | 0.01% |
| HighMark Wealth Management LLC | 2,039 | $14,000 | 0.01% |
| Renaissance Technologies | 341,422 | $2,356,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 34,618 | $240,000 | 0.00% |